Basic Information

Email Address

• Email Address

  fukasawa.toshiki.4akyoto-u.ac.jp

Professional Memberships

• From Jun. 2025, To Present

  Society for Epidemiologic Research
• From Aug. 2017, To Present

  Japan Epidemiological Association
• From May 2018, To Present

  Society for Clinical Epidemiology
• From Jun. 2018, To Present

  Japanese Society for Pharmacoepidemiology
• From Nov. 2018, To Jul. 2020

  Pharmaceutical Society of Japan
• From Jul. 2019, To Jun. 2020

  International Society for Pharmacoepidemiology
• From Jan. 2024, To Present

  International Society for Pharmacoepidemiology

Academic Degree

• 2024

  Doctor of Philosophy (Kyoto University)
• 2019

  Master of Pharmaceutical Sciences (Keio University)
• 2017

  Bachelor of Pharmaceutical Sciences (Keio University)

Academic Resume (Graduate Schools)

• Keio University, Graduate School of Pharmaceutical Sciences, Pharmaceutical Sciences (Master's Program), 修了

Academic Resume (Undergraduate School/Majors)

• Keio University, Faculty of Pharmacy, Department of Pharmaceutical Sciences, 卒業

Research History

• From Nov. 2024, To Present

  Kyoto University, Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Program-Specific Junior Associate Professor
• From Jul. 2024, To Present

  JMDC Inc., Real World Evidence Division, Pharmaceutical Business Unit, Advisor
• From Aug. 2020, To Jul. 2024

  Real World Data Co., Ltd., Research and Analytics Department, Senior Consultant
• From Jul. 2020, To Oct. 2024

  Kyoto University, Department of Pharmacoepidemiology and Department of Digital Health and Epidemiology, Graduate School of Medicine and Public Health, Program-Specific Assistant Professor
• From Apr. 2019, To Mar. 2021

  Keio University, Division of Drug Development and Regulatory Science, Graduate School of Pharmaceutical Sciences, Co-Investigator
• From Apr. 2019, To Jun. 2020

  Tohoku University Hospital, Department of Development Promotion, Clinical Research, Innovation and Education Center, Research Associate

Profile

• Profile

  Toshiki Fukasawa is a Program-Specific Junior Associate Professor in the Department of Pharmacoepidemiology at the Kyoto University School of Public Health. His research focuses on evaluating drug utilization, safety, and effectiveness across multiple therapeutic areas using electronic healthcare databases.

  
  

  Selected Publications:

  
  

  • Masuda S, Fukasawa T, Matsuda S, Kawakami K. Cardiovascular Safety and Fracture Prevention Effectiveness of Denosumab Versus Oral Bisphosphonates in Patients Receiving Dialysis: A Target Trial Emulation. Ann Intern Med. 2025;178(2):167-176.

  
  

  • Anno T, Fukasawa T, Shinozaki T, Takeuchi M, Yoshida S, Kawakami K. Impact of Early Resumption of Oral Anticoagulation on Recurrence After Surgery for Chronic Subdural Hematoma in Patients With Atrial Fibrillation: A Target Trial Emulation. Pharmacoepidemiol Drug Saf. 2024;33(12):e70063.

  
  

  • Fukasawa T, Urushihara H, Takahashi H, Okura T, Kawakami K. Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Associated With Antibiotic Use: A Case-Crossover Study. J Allergy Clin Immunol Pract. 2023;11(11):3463-3472.

ID,URL

• ORCID ID

  0000-0001-7147-0737

• J-Global ID

  201901014253484701

• Researcher ID

  I-6282-2018

• Researcher number

  40852702

• External link

  https://kupe.med.kyoto-u.ac.jp/index_e.html

Website(s) (URL(s))

• https://www.linkedin.com/in/toshikifukasawa/en

researchmap URL

• https://researchmap.jp/toshikifukasawa

Research

Research Interests

• Pharmacoepidemiology
• Clinical epidemiology
• Data-driven healthcare
• Epidemiology
• Observational studies
• Real-world data
• Dialysis

Research Areas

• Informatics, Biological, health, and medical informatics
• Life sciences, Clinical pharmacy
• Life sciences, Hygiene and public health (non-laboratory)
• Life sciences, Healthcare management, medical sociology

Papers

• Clinical Characteristics and Outcomes of Pregnancy-Associated Venous Thromboembolism ― Report From the Japanese Nationwide Hospital Administrative Database ―

  Daisuke Baba; Yugo Yamashita; Toshiki Fukasawa; Chikashi Takeda; Wei Xiong; Takahiro Horie; Koh Ono

  Circulation Journal, Jun. 2025, Peer-reviewed

  
• Treatment trends and outcomes of pyogenic vertebral osteomyelitis in Japan, 2015–2023: A descriptive epidemiological study

  Takaki Yoshiyama; Toshiki Fukasawa; Soichiro Masuda; Bungo Otsuki; Koichi Murata; Takayoshi Shimizu; Takashi Sono; Shintaro Honda; Koichiro Shima; Masaki Sakamoto; Ryohei Saito; Shuichi Matsuda; Koji Kawakami

  Journal of Orthopaedic Science, Jun. 2025, Peer-reviewed

  
• Temporal trends in management strategies and clinical outcomes of venous thromboembolism in Japan from 2017 to 2023

  Wei Xiong; Yugo Yamashita; Toshiki Fukasawa; Chikashi Takeda; Hiroki Shiomi; Takahiro Horie; Koh Ono

  Journal of Cardiology, Mar. 2025, Peer-reviewed

  
• Cefazolin vs. Alternative Beta-lactams for Prophylaxis in Lower Extremity Fracture Surgery: A Target Trial Emulation

  Takaki Yoshiyama; Toshiki Fukasawa; Soichiro Masuda; Shuichi Matsuda; Koji Kawakami

  Injury, Feb. 2025, Peer-reviewed

  
• Effects of Reimbursement Add-On Policies on Trastuzumab and Bevacizumab Biosimilar Adoption in a Japanese Oncology Setting

  Hiroaki Mamiya; Toshiki Fukasawa; Koji Kawakami

  Value in Health Regional Issues, Mar. 2025, Peer-reviewed

  Access this paper :

  
• Risk of Fracture Associated with Pregabalin or Mirogabalin Use: A Case-Case-Time-Control Study Based on Japanese Health Insurance Claims Data

  Hinako Wakabayashi; Toshiki Fukasawa; Satomi Yoshida; Kairi Ri; Soichiro Masuda; Takayuki Anno; Koji Kawakami

  Drug Safety, May 2025, Peer-reviewed

  
• Comparative effectiveness, persistence, and adherence of dimethyl fumarate and fingolimod in patients with multiple sclerosis in Japan: A cohort study

  Sho Shimazaki; Toshiki Fukasawa; Takayuki Kondo; Masato Takeuchi; Takayuki Okura; Ryosuke Takahashi; Koji Kawakami

  Multiple Sclerosis and Related Disorders, Feb. 2025, Peer-reviewed

  
• Cardiovascular Safety and Fracture Prevention Effectiveness of Denosumab Versus Oral Bisphosphonates in Patients Receiving Dialysis: A Target Trial Emulation

  Soichiro Masuda; Toshiki Fukasawa; Shuichi Matsuda; Koji Kawakami

  Annals of Internal Medicine, Feb. 2025, Peer-reviewed

  
• Initiation of Psychotropic Drugs in Spouses of Patients With Early‐Onset Alzheimer's Disease: A Matched Cohort Study

  Toshiki Fukasawa; Kota Matsumoto; Kotaro Sasaki; Yukako Nakagami; Yuta Goto; Yusuke Sakamoto; Yukihiko Washimi; Sachiko Tanaka‐Mizuno; Satomi Yoshida; Kayoko Mizuno; Yuta Kamada; Mika Ishii; Koji Kawakami

  International Journal of Geriatric Psychiatry, Jan. 2025, Peer-reviewed, Lead author

  
• Comparative renoprotective effectiveness of allopurinol and febuxostat among hyperuricemic patients with preserved kidney function

  Atsushi Takayama; Toshiki Fukasawa; Masato Takeuchi; Koji Kawakami

  Modern Rheumatology, Dec. 2024, Peer-reviewed

  
• Early prediction of functional impairment at hospital discharge in patients with osteoporotic vertebral fracture: a machine learning approach

  Soichiro Masuda; Toshiki Fukasawa; Shoichiro Inokuchi; Bungo Otsuki; Koichi Murata; Takayoshi Shimizu; Takashi Sono; Shintaro Honda; Koichiro Shima; Masaki Sakamoto; Shuichi Matsuda; Koji Kawakami

  Scientific Reports, Dec. 2024, Peer-reviewed

  Access this paper :

  
• Assessing the Risk of Gastrointestinal Perforation Associated with COVID-19: A Self-Controlled Case Series Study

  Takayuki Okura; Sachiko Tanaka-Mizuno; Toshiki Fukasawa; Satomi Yoshida; Koji Kawakami

  American Journal of Epidemiology, Dec. 2024, Peer-reviewed

  
• Impact of Early Resumption of Oral Anticoagulation on Recurrence After Surgery for Chronic Subdural Hematoma in Patients With Atrial Fibrillation: A Target Trial Emulation

  Takayuki Anno; Toshiki Fukasawa; Tomohiro Shinozaki; Masato Takeuchi; Satomi Yoshida; Koji Kawakami

  Pharmacoepidemiology and Drug Safety, Dec. 2024, Peer-reviewed

  
• Comparison of reoperation incidence after fusion versus decompression for lumbar degenerative disease: A propensity score-weighted study

  Soichiro Masuda; Toshiki Fukasawa; Shunsuke Fujibayashi; Bungo Otsuki; Koichi Murata; Takayoshi Shimizu; Shuichi Matsuda; Koji Kawakami

  Annals of Clinical Epidemiology, Jan. 2025, Peer-reviewed

  Access this paper :

  
• Real-world treatment patterns and outcomes of patients with unresectable or metastatic urothelial carcinoma receiving systemic therapy in Japan

  Shotaro Yasuoka; Toshihiko Minegishi; Shingo Kojima; Kotoba Okuyama; Toshiki Fukasawa; Mizuho Akahane; Hidetoshi Uenaka; Yuichiro Ito; Makito Miyake

  Urologic Oncology: Seminars and Original Investigations, May 2025, Peer-reviewed

  
• Comparative effectiveness and cardiovascular safety of romosozumab versus teriparatide in patients with osteoporosis: a population-based cohort study

  Soichiro Masuda; Toshiki Fukasawa; Shuichi Matsuda; Satomi Yoshida; Koji Kawakami

  Osteoporosis International, Dec. 2024, Peer-reviewed

  
• Evaluation of prescribing patterns of switching to and add-on lemborexant in patients treated with hypnotic medication: a nationwide claims database study in Japan

  Sachiko Tanaka-Mizuno; Kenichi Fujimoto; Kazuo Mishima; Yukinori Sakata; Toshiki Fukasawa; Kayoko Mizuno; Satomi Yoshida; Mika Ishii; Takehiro Taninaga; Naoki Kubota; Margaret Moline; Koji Kawakami

  Expert Opinion on Pharmacotherapy, Aug. 2024, Peer-reviewed

  
• Unchanged incidence of major adverse events amidst rising surgical interventions for osteoporotic vertebral fractures, 2015–2021

  Soichiro Masuda; Toshiki Fukasawa; Bungo Otsuki; Koichi Murata; Takayoshi Shimizu; Takashi Sono; Shintaro Honda; Koichiro Shima; Masaki Sakamoto; Shuichi Matsuda; Koji Kawakami

  Archives of Osteoporosis, Aug. 2024, Peer-reviewed

  
• Narcolepsy and risk of traumatic injury: a population-based matched cohort study

  Yunlong Zheng; Toshiki Fukasawa; Soichiro Masuda; Masato Takeuchi; Koji Kawakami

  Journal of Clinical Sleep Medicine, Oct. 2024, Peer-reviewed

  
• Adherence to istradefylline in patients with Parkinson's disease: A group-based trajectory analysis

  Toshiki Fukasawa; Etsuro Nakanishi; Hiroo Shimoda; Katsumi Shinoda; Satoru Ito; Shinji Asada; Satomi Yoshida; Sachiko Tanaka-Mizuno; Kayoko Mizuno; Ryosuke Takahashi; Koji Kawakami

  Journal of the Neurological Sciences, Jul. 2024, Peer-reviewed, Lead author

  
• Incidence, Prevalence, and Treatment of Moyamoya Disease in Japan: A Population-based Descriptive Study

  Hao Liu; Toshiki Fukasawa; Takayuki Anno; Masato Takeuchi; Sho Shimazaki; Tao Yang; Koji Kawakami

  Journal of Stroke and Cerebrovascular Diseases, Aug. 2024, Peer-reviewed

  
• Timing of Initiation of Xanthine Oxidase Inhibitors Based on Serum Uric Acid Level Does Not Predict Renoprognosis in Patients with Preserved Kidney Function

  Atsushi Takayama; Toshiki Fukasawa; Masato Takeuchi; Koji Kawakami

  Metabolic Syndrome and Related Disorders, Apr. 2024, Peer-reviewed

  
• Glucocorticoid treatment and clinical outcomes in patients with polymyalgia rheumatica: A cohort study using routinely collected health data

  Yoshiya Tanaka; Shinichi Tanaka; Toshiki Fukasawa; Shoichiro Inokuchi; Hidetoshi Uenaka; Takeshi Kimura; Toshiya Takahashi; Naoto Kato

  Joint Bone Spine, May 2024, Peer-reviewed

  
• Clinical Characteristics and Outcomes of Patients With Venous Thromboembolism Receiving Edoxaban in the Real World

  Yugo Yamashita; Toshiki Fukasawa; Chikashi Takeda; Masato Takeuchi; Koh Ono; Koji Kawakami

  Circulation Journal, Feb. 2024, Peer-reviewed, Lead author

  
• Cardiovascular Safety of Atomoxetine and Methylphenidate in Patients With Attention-Deficit/Hyperactivity Disorder in Japan: A Self-Controlled Case Series Study

  Yunlong Zheng; Toshiki Fukasawa; Fumitaka Yamaguchi; Masato Takeuchi; Koji Kawakami

  Journal of Attention Disorders, Feb. 2024, Peer-reviewed

  
• Frequency and determinants of serum calcium monitoring during eldecalcitol therapy in patients with osteoporosis

  Kairi Ri; Toshiki Fukasawa; Soichiro Masuda; Shiro Tanaka; Masato Takeuchi; Satomi Yoshida; Koji Kawakami

  Journal of Bone and Mineral Metabolism, Nov. 2023, Peer-reviewed

  
• Association between dental procedures and periprosthetic joint infection: A case-crossover study

  Soichiro Masuda; Toshiki Fukasawa; Masato Takeuchi; Korenori Arai; Shuichi Matsuda; Koji Kawakami

  Journal of Orthopaedic Science, Jul. 2024, Peer-reviewed

  
• Are Dental Procedures Associated With Pyogenic Vertebral Osteomyelitis?

  Soichiro Masuda; Toshiki Fukasawa; Masato Takeuchi; Korenori Arai; Shunsuke Fujibayashi; Bungo Otsuki; Koichi Murata; Takayoshi Shimizu; Shuichi Matsuda; Koji Kawakami

  Clinical Orthopaedics and Related Research, Apr. 2024, Peer-reviewed

  
• Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Associated With Antibiotic Use: A Case-Crossover Study

  Toshiki Fukasawa; Hisashi Urushihara; Hayato Takahashi; Takayuki Okura; Koji Kawakami

  The Journal of Allergy and Clinical Immunology: In Practice, Nov. 2023, Peer-reviewed, Lead author

  
• Adherence to and persistence with lacosamide, perampanel, lamotrigine, and levetiracetam in adult patients with focal epilepsy in Japan: A descriptive cohort study using a claims database

  Siming Chen; Toshiki Fukasawa; Akio Ikeda; Masato Takeuchi; Akihiro Shimotake; Satomi Yoshida; Koji Kawakami

  Heliyon, Mar. 2023, Peer-reviewed

  
• Predictors of the Need for Surgery in Cervical Ossification of the Posterior Longitudinal Ligament

  Soichiro Masuda; Toshiki Fukasawa; Masato Takeuchi; Shunsuke Fujibayashi; Bungo Otsuki; Koichi Murata; Takayoshi Shimizu; Shuichi Matsuda; Koji Kawakami

  Clinical Spine Surgery: A Spine Publication, Jul. 2023, Peer-reviewed

  
• Incidence of Surgical Site Infection Following Lateral Lumbar Interbody Fusion Compared With Posterior/Transforaminal Lumbar Interbody Fusion

  Soichiro Masuda; Toshiki Fukasawa; Masato Takeuchi; Shunsuke Fujibayashi; Bungo Otsuki; Koichi Murata; Takayoshi Shimizu; Shuichi Matsuda; Koji Kawakami

  Spine, Jul. 2023, Peer-reviewed

  
• Risk of parkinsonism and related movement disorders with gabapentinoids or tramadol: A case‐crossover study

  Kairi Ri; Toshiki Fukasawa; Satomi Yoshida; Masato Takeuchi; Koji Kawakami

  Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Feb. 2023, Peer-reviewed

  
• Clinical epidemiology and pharmacoepidemiology studies with real-world databases

  Satomi Yoshida; Masato Takeuchi; Sachiko Tanaka-Mizuno; Kayoko Mizuno; Masayuki Nakashima; Toshiki Fukasawa; Koji Kawakami

  Proceedings of the Japan Academy, Series B, Dec. 2022, Peer-reviewed, Invited

  Access this paper :

  
• Reoperation Rates of Microendoscopic Discectomy Compared With Conventional Open Lumbar Discectomy: A Large-database Study

  Soichiro Masuda; Toshiki Fukasawa; Masato Takeuchi; Shunsuke Fujibayashi; Bungo Otsuki; Koichi Murata; Takayoshi Shimizu; Shuichi Matsuda; Koji Kawakami

  Clinical Orthopaedics and Related Research, Jan. 2023, Peer-reviewed

  
• Comparative effectiveness and safety of edoxaban, rivaroxaban, and apixaban in patients with venous thromboembolism: A cohort study

  Toshiki Fukasawa; Tomotsugu Seki; Masayuki Nakashima; Koji Kawakami

  Journal of Thrombosis and Haemostasis, Sep. 2022, Peer-reviewed, Lead author

  
• Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with anticonvulsants in a Japanese population: Matched case–control and cohort studies

  Toshiki Fukasawa; Hayato Takahashi; Kunihiko Takahashi; Nanae Tanemura; Masayuki Amagai; Hisashi Urushihara

  Allergology International, Jul. 2021, Peer-reviewed, Lead author

  
• Utility of a Specific Health Checkup Database Containing Lifestyle Behaviors and Lifestyle Diseases for Employee Health Insurance in Japan

  Toshiki Fukasawa; Nanae Tanemura; Shinya Kimura; Hisashi Urushihara

  Journal of Epidemiology, Feb. 2020, Peer-reviewed, Lead author

  
• Development of an electronic medical record-based algorithm to identify patients with Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan

  Toshiki Fukasawa; Hayato Takahashi; Norin Kameyama; Risa Fukuda; Shihori Furuhata; Nanae Tanemura; Masayuki Amagai; Hisashi Urushihara

  PLOS ONE, Aug. 2019, Peer-reviewed, Lead author

  

Misc.

• 

  Target Trial Emulation: A Framework for Strengthening Causal Inference in Observational Studies

  Toshiki Fukasawa; Tomohiro Shinozaki

  Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku, Jun. 2025, Lead author, Corresponding author

  
• 

  Special Issue on “Target Trial Emulation: A New Paradigm for Causal Inference in Observational Studies” Preface

  Toshiki Fukasawa

  Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku, Jun. 2025, Lead author, Last author, Corresponding author

  
• Methodological concerns, implausibly early fracture reduction, and potential outcome misclassification: Comment on “Comparative effectiveness of romosozumab versus teriparatide for fracture prevention: A new-user, active comparator design”

  Soichiro Masuda; Toshiki Fukasawa; Shuichi Matsuda; Koji Kawakami

  Bone, May 2025, Peer-reviewed

  
• Author response to: OSIN-D-24–01586, “Revisiting the safety of romosozumab in Japan: the need for clear contraindications for patients with cardiovascular risk”

  Soichiro Masuda; Toshiki Fukasawa; Shuichi Matsuda; Satomi Yoshida; Koji Kawakami

  Osteoporosis International, Mar. 2025, Peer-reviewed

  
• Erratum to: Reoperation Rates of Microendoscopic Discectomy Compared With Conventional Open Lumbar Discectomy: A Large-database Study

  Soichiro Masuda; Toshiki Fukasawa; Masato Takeuchi; Shunsuke Fujibayashi; Bungo Otsuki; Koichi Murata; Takayoshi Shimizu; Shuichi Matsuda; Koji Kawakami

  Clinical Orthopaedics and Related Research, Mar. 2024

  
• 

  Design Diagram: A Framework for Visualizing Study Designs Using Real-world Data and Improving Study Reproducibility

  Toshiki Fukasawa; Masao Iwagami; Azusa Hara; Hisashi Urushihara

  Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku, Oct. 2023, Lead author, Corresponding author

  
• 

  HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real-world Evidence Studies on Treatment Effects (Japanese Version)： A Good Practices Report of a Joint ISPE/ISPOR Task Force

  Toshiki Fukasawa; Masao Iwagami; Azusa Hara; Takahiro Nonaka; Hisashi Urushihara

  Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku, Jun. 2023, Peer-reviewed, Lead author

  
• 

  序文 HARPERの翻訳および関連する本企画について

  Toshiki Fukasawa; Masao Iwagami; Azusa Hara; Takahiro Nonaka; Hisashi Urushihara

  Japanese Journal of Pharmacoepidemiology/Yakuzai ekigaku, Jun. 2023, Lead author

  
• 【腎疾患における臨床研究の進歩】国内データベースの活用 レセプトデータベース

  Toshiki Fukasawa; Sachiko Tanaka-Mizuno; Koji Kawakami

  Kidney and Dialysis, Sep. 2022, Invited, Lead author

  
• 

  【最近の疫学】医療データベースを用いた観察研究の可能性

  Toshiki Fukasawa; Sachiko Tanaka-Mizuno; Koji Kawakami

  Farumashia, Aug. 2022, Peer-reviewed, Invited, Lead author

  

Presentations

• 小児における睡眠薬の使用実態：診療報酬請求データベースを用いた記述疫学研究

  田中 佐智子; 藤本 健一; 三島 和夫; 阪田 幸則; 深澤 俊貴; 水野 佳世子; 古戎 道典; 久保田 直樹; Margaret Moline; 石井 美佳; 川上 浩司

  The 49th Annual Meeting of the Japanese Society of Sleep Research, 28 Jun. 2025, Japanese Society of Sleep Research

  
• Clinical Characteristics and Outcomes of Venous Thromboembolism Associated with Pregnancy: Report from Nationwide Administrative Database

  Daisuke Baba; Toshiki Fukasawa; Yugo Yamashita; Chikashi Takeda; Takahiro Horie; Koh Ono

  The 89th Annual Scientific Meeting of the Japanese Circulation Society, 28 Mar. 2025, Japanese Circulation Society

  
• A Descriptive Epidemiological Study of Pediatric Sleep Medications in Japan: A Health Insurance Claims-Based Analysis

  Kenichi Fujimoto; Sachiko Tanaka-Mizuno; Kazuo Mishima; Yukinori Sakata; Naoki Kubota; Michinori Koebisu; Toshiki Fukasawa; Kayoko Mizuno; Mika Ishii; Margaret Moline; Koji Kawakami

  ISPOR Europe 2024, 19 Nov. 2024, ISPOR—The Professional Society for Health Economics and Outcomes Research

  
• ロモソズマブとテリパラチドの骨折予防効果ならびに心血管リスクの比較

  Soichiro Masuda; Toshiki Fukasawa; Shuichi Matsuda; Satomi Yoshida; Koji Kawakami

  The 26th Annual Meeting of Japan Osteoporosis Society, 11 Oct. 2024, Japan Osteoporosis Society

  
• 入院加療を要する骨粗鬆症性椎体骨折患者の退院時ADL不良の予測モデルの開発と検証

  Soichiro Masuda; Toshiki Fukasawa; Shoichiro Inokuchi; Bungo Otsuki; Koichi Murata; Takayoshi Shimizu; Takashi Sono; Shintaro Honda; Koichiro Shima; Masaki Sakamoto; Shuichi Matsuda; Koji Kawakami

  The 26th Annual Meeting of Japan Osteoporosis Society, 11 Oct. 2024, Japan Osteoporosis Society

  
• 若年性アルツハイマー型認知症患者の配偶者における精神疾患治療薬の新規使用率

  Kota Matsumoto; Kotaro Sasaki; Toshiki Fukasawa; Yukako Nakagami; Yuta Goto; Yusuke Sakamoto; Yukihiko Washimi; Sachiko Tanaka-Mizuno; Satomi Yoshida; Kayoko Mizuno; Yuta Kamada; Mika Ishii; Koji Kawakami

  The 43rd Annual Meeting of Japan Society for Dementia Research, 21 Nov. 2024, 日本認知症学会

  
• Risk of Fracture Associated with Pregabalin or Mirogabalin Use: A Case-Case-Time-Control Study

  Hinako Wakabayashi; Toshiki Fukasawa; Satomi Yoshida; Kairi Ri; Soichiro Masuda; Takayuki Anno; Koji Kawakami

  The 16th Asian Conference on Pharmacoepidemiology, 13 Oct. 2024, International Society for Pharmacoepidemiology/Japanese Society for Pharmacoepidemiology

  
• 

  Early-Career Pharmacoepidemiologists: Perspectives and Progress from Asia

  Toshiki Fukasawa; Na-young Jeong; Jui Wang; Eric Wan; Nhung TH Trinh

  The 16th Asian Conference on Pharmacoepidemiology, 14 Oct. 2024, International Society for Pharmacoepidemiology/Japanese Society for Pharmacoepidemiology, Invited

  
• 入院加療を要する骨粗鬆症性椎体骨折患者に対する治療法の変遷が全身合併症発生頻度に与える影響

  Soichiro Masuda; Toshiki Fukasawa; Bungo Otsuki; Koichi Murata; Takayoshi Shimizu; Takashi Sono; Shintaro Honda; Koichiro Shima; Masaki Sakamoto; Shuichi Matsuda; Koji Kawakami

  The 97th Annual Meeting of the Japanese Orthopaedic Association, 26 May 2024, Japanese Orthopaedic Association

  
• 頚椎後縦靱帯骨化症に対する前方除圧固定術と後方除圧固定術の術後再手術率と医療費の比較

  Soichiro Masuda; Toshiki Fukasawa; Bungo Otsuki; Koichi Murata; Takayoshi Shimizu; Takashi Sono; Shintaro Honda; Koichiro Shima; Masaki Sakamoto; Shuichi Matsuda; Koji Kawakami

  The 97th Annual Meeting of the Japanese Orthopaedic Association, 25 May 2024, Japanese Orthopaedic Association

  
• 歯科処置と化膿性脊椎炎の関連 ―ケース・クロスオーバー研究―

  Soichiro Masuda; Toshiki Fukasawa; Masato Takeuchi; Korenori Arai; Bungo Otsuki; Koichi Murata; Takayoshi Shimizu; Shuichi Matsuda; Koji Kawakami

  The 97th Annual Meeting of the Japanese Orthopaedic Association, 25 May 2024, Japanese Orthopaedic Association

  
• 高齢者における骨粗鬆症性椎体骨折の治療トレンドとその影響

  Soichiro Masuda; Toshiki Fukasawa; Bungo Otsuki; Koichi Murata; Takayoshi Shimizu; Takashi Sono; Shintaro Honda; Koichiro Shima; Masaki Sakamoto; Shuichi Matsuda; Koji Kawakami

  The 53rd Annual Meeting of the Japanese Society for Spine Surgery and Related Research, 20 Apr. 2024, Japanese Society for Spine Surgery and Related Research

  
• 歯科処置は化膿性脊椎炎発症と関連しているか：ケースクロスオーバー研究による評価

  Soichiro Masuda; Toshiki Fukasawa; Masato Takeuchi; Korenori Arai; Bungo Otsuki; Koichi Murata; Takayoshi Shimizu; Shuichi Matsuda; Koji Kawakami

  The 53rd Annual Meeting of the Japanese Society for Spine Surgery and Related Research, 19 Apr. 2024, Japanese Society for Spine Surgery and Related Research

  
• Comparison of Reoperation Rates and Cost after Anterior vs. Posterior Decompression and Fusion for Cervical OPLL

  Soichiro Masuda; Toshiki Fukasawa; Bungo Otsuki; Koichi Murata; Takayoshi Shimizu; Takashi Sono; Shintaro Honda; Koichiro Shima; Masaki Sakamoto; Shuichi Matsuda; Koji Kawakami

  The 53rd Annual Meeting of the Japanese Society for Spine Surgery and Related Research, 18 Apr. 2024, Japanese Society for Spine Surgery and Related Research

  
• Adherence patterns of istradefylline treatment in patients with Parkinson’s disease: A group-based trajectory analysis

  Etsuro Nakanishi; Toshiki Fukasawa; Katsumi Shinoda; Hiroo Shimoda; Satoru Ito; Shinji Asada; Satomi Yoshida; Sachiko Tanaka-Mizuno; Kayoko Mizuno; Ryosuke Takahashi; Koji Kawakami

  The 3rd Annual Advanced Therapeutics in Movement & Related Disorders Congress, 24 Jun. 2024, Parkinson & Movement Disorder Alliance

  
• Treatment patterns and outcomes of Japanese patients with unresectable or metastatic urothelial carcinoma receiving first-line chemotherapy

  Shotaro Yasuoka; Toshihiko Minegishi; Shingo Kojima; Kotoba Okuyama; Toshiki Fukasawa; Mizuho Akahane; Hidetoshi Uenaka; Yuichiro Ito; Makito Miyake

  The 111th Annual Meeting of the Japanese Urological Association, 27 Apr. 2024, Japanese Urological Association

  
• パーキンソン病患者におけるイストラデフィリン治療の服薬アドヒアランスパターン

  Etsuro Nakanishi; Toshiki Fukasawa; Katsumi Shinoda; Hiroo Shimoda; Satoru Ito; Shinji Asada; Satomi Yoshida; Sachiko Tanaka-Mizuno; Kayoko Mizuno; Ryosuke Takahashi; Koji Kawakami

  The 65th Annual Meeting of the Japanese Society of Neurology, 01 Jun. 2024, Japanese Society of Neurology

  
• 若年性アルツハイマー型認知症患者の配偶者における気分障害治療薬の新規使用率

  Kota Matsumoto; Kotaro Sasaki; Toshiki Fukasawa; Yukako Nakagami; Yuta Goto; Yusuke Sakamoto; Sachiko Tanaka-Mizuno; Satomi Yoshida; Kayoko Mizuno; Mika Ishii; Koji Kawakami

  The 94th Annual Meeting of the Japanese Society for Hygiene, 08 Mar. 2024, Japanese Society for Hygiene

  
• HARPER - リアルワールドエビデンス研究の再現性向上に向けた調和プロトコルテンプレート

  Toshiki Fukasawa; Azusa Hara

  The 28th Conference of the Japanese Society for Pharmacoepidemiology, 18 Nov. 2023, Japanese Society for Pharmacoepidemiology

  
• ナルコレプシー患者における外傷性損傷の発生リスク：マッチド・コホート研究

  Yunlong Zheng; Toshiki Fukasawa; Soichiro Masuda; Masato Takeuchi; Koji Kawakami

  The 6th Annual Meeting of the Society for Clinical Epidemiology, 11 Nov. 2023, Society for Clinical Epidemiology

  
• 心房細動患者における慢性硬膜下血腫術後の経口抗凝固薬早期再開と再発の関連：標的試験エミュレーション

  Takayuki Anno; Toshiki Fukasawa; Tomohiro Shinozaki; Masato Takeuchi; Satomi Yoshida; Koji Kawakami

  The 6th Annual Meeting of the Society for Clinical Epidemiology, 11 Nov. 2023, Society for Clinical Epidemiology

  
• 歯科処置と化膿性脊椎炎の関連：ケース・クロスオーバー研究

  Soichiro Masuda; Toshiki Fukasawa; Masato Takeuchi; Korenori Arai; Shunsuke Fujibayashi; Bungo Otsuki; Koichi Murata; Takayoshi Shimizu; Shuichi Matsuda; Koji Kawakami

  The 6th Annual Meeting of the Society for Clinical Epidemiology, 11 Nov. 2023, Society for Clinical Epidemiology

  
• レンボレキサントへの切り替えの実態：診療報酬請求データベースを用いた記述疫学研究

  Sachiko Tanaka-Mizuno; Kenichi Fujimoto; Kazuo Mishima; Yukinori Sakata; Toshiki Fukasawa; Kayoko Mizuno; Satomi Yoshida; Mika Ishii; Takehiro Taninaga; Naoki Kubota; Margaret Moline; Koji Kawakami

  Joint Congress of the 45th Annual Meeting of the Japanese Society of Sleep Research and the 30th Annual Meeting of the Japanese Society for Chronobiology, 16 Sep. 2023, Japanese Society of Sleep Research/Japanese Society for Chronobiology

  
• 腰椎側方椎体間固定術と腰椎後方椎体間固定術の術後創部感染発生率の比較

  Soichiro Masuda; Toshiki Fukasawa; Masato Takeuchi; Shunsuke Fujibayashi; Bungo Otsuki; Koichi Murata; Takayoshi Shimizu; Shuichi Matsuda; Koji Kawakami

  The 96th Annual Meeting of the Japanese Orthopaedic Association, 13 May 2023, Japanese Orthopaedic Association

  
• 腰部脊柱管狭窄症に対する固定術は除圧術単独と比較し再手術率低下と関連する

  Soichiro Masuda; Toshiki Fukasawa; Shunsuke Fujibayashi; Bungo Otsuki; Koichi Murata; Takayoshi Shimizu; Shuichi Matsuda; Koji Kawakami

  The 96th Annual Meeting of the Japanese Orthopaedic Association, 13 May 2023, Japanese Orthopaedic Association

  
• The reoperation rate of fusion surgery compared with decompression alone for lumbar spinal stenosis

  Soichiro Masuda; Toshiki Fukasawa; Shunsuke Fujibayashi; Bungo Otsuki; Koichi Murata; Takayoshi Shimizu; Shuichi Matsuda; Koji Kawakami

  The 52nd Annual Meeting of the Japanese Society for Spine Surgery and Related Research, 14 Apr. 2023, 日本脊椎脊髄病学会

  
• Incidence of surgical site infection following lateral lumbar interbody fusion compared with posterior lumbar interbody fusion

  Soichiro Masuda; Toshiki Fukasawa; Masato Takeuchi; Shunsuke Fujibayashi; Bungo Otsuki; Koichi Murata; Takayoshi Shimizu; Shuichi Matsuda; Koji Kawakami

  The 52nd Annual Meeting of the Japanese Society for Spine Surgery and Related Research, 13 Apr. 2023, 日本脊椎脊髄病学会

  
• 腰椎側方椎体間固定術と腰椎後方椎体間固定術の術後創部感染発生率の比較

  Soichiro Masuda; Toshiki Fukasawa; Masato Takeuchi; Shunsuke Fujibayashi; Bungo Otsuki; Koichi Murata; Takayoshi Shimizu; Shuichi Matsuda; Koji Kawakami

  The 5th Annual Meeting of the Society for Clinical Epidemiology, 13 Nov. 2022, Society for Clinical Epidemiology

  
• 日本薬剤疫学会拡充委員会 The JSPE Youthful Experience：研究立ち上げから論文化に至るまでの一連の流れに関する座談会

  Toshiki Fukasawa; Shunsaku Nakagawa; Tomofumi Ishikawa

  The 27th Conference of the Japanese Society for Pharmacoepidemiology, 18 Nov. 2022, Japanese Society for Pharmacoepidemiology

  
• Comparative effectiveness, persistence, and adherence of dimethyl fumarate and fingolimod in patients with multiple sclerosis

  Sho Shimazaki; Toshiki Fukasawa; Takayuki Kondo; Masato Takeuchi; Takayuki Okura; Ryosuke Takahashi; Koji Kawakami

  The 27th Conference of the Japanese Society for Pharmacoepidemiology, 18 Nov. 2022, Japanese Society for Pharmacoepidemiology

  
• Working theater：研究デザインを視覚化し、研究の再現性を高めるDesign diagram

  Koji Kawakami; Toshiki Fukasawa; Atsushi Takayama

  Pre-seminar for the 5th Annual Meeting of the Society for Clinical Epidemiology, 05 Nov. 2022, Society for Clinical Epidemiology

  
• 抗菌薬・抗真菌薬の使用とスティーヴンス・ジョンソン症候群及び中毒性表皮壊死症のリスク

  Toshiki Fukasawa; Hisashi Urushihara; Hayato Takahashi; Koji Kawakami

  The 26th Conference of the Japanese Society for Pharmacoepidemiology, 28 Nov. 2021, Japanese Society for Pharmacoepidemiology

  
• ガバペンチノイドおよびトラマドールによる錐体外路症状のリスク：ケース・クロスオーバー研究

  Kairi Ri; Toshiki Fukasawa; Satomi Yoshida; Masato Takeuchi; Koji Kawakami

  The 26th Conference of the Japanese Society for Pharmacoepidemiology, 27 Nov. 2021, Japanese Society for Pharmacoepidemiology

  
• ARO協議会の会員施設における医師主導治験の結果公表状況

  Nozomi Yabuuchi; Toshiki Fukasawa; Shiro Fukumori; Koji Ikeda; Hideo Harigae

  The 8th Annual Meeting of the Academic Research Organization, 10 Sep. 2021, Academic Research Organization

  
• 医師主導治験の結果公表状況

  Toshiki Fukasawa; Koji Ikeda; Hiroaki Shimokawa

  The 7th Annual Meeting of the Academic Research Organization, 27 Sep. 2019, Academic Research Organization

  
• Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with anticonvulsants in a Japanese population

  Toshiki Fukasawa; Hayato Takahashi; Nanae Tanemura; Masayuki Amagai; Hisashi Urushihara

  The 35th International Conference on Pharmacoepidemiology & Therapeutic Risk Management, 27 Aug. 2019, International Society for Pharmacoepidemiology

  
• 抗てんかん薬によるスティーブンス・ジョンソン症候群および中毒性表皮壊死症発症のリスク評価

  Toshiki Fukasawa; Hayato Takahashi; Nanae Tanemura; Hisashi Urushihara

  The 139th Annual Meeting of the Pharmaceutical Society of Japan, 21 Mar. 2019, Pharmaceutical Society of Japan

  
• 電子カルテデータからスティーブンス・ジョンソン症候群および中毒性表皮壊死症を特定するアルゴリズムの検討

  Toshiki Fukasawa; Hayato Takahashi; Norin Kameyama; Risa Fukuda; Shihori Furuhata; Nanae Tanemura; Masayuki Amagai; Hisashi Urushihara

  The 24th Conference of the Japanese Society for Pharmacoepidemiology, 14 Oct. 2018, Japanese Society for Pharmacoepidemiology

  
• 健康保険組合加入者の生活習慣および生活習慣病の実態調査：国民健康・栄養調査との比較

  Toshiki Fukasawa; Nanae Tanemura; Hisashi Urushihara

  The 28th Annual Scientific Meeting of the Japan Epidemiological Association, 02 Feb. 2018, Japan Epidemiological Association

  

Awards

• 28 Nov. 2021

  Japanese Society for Pharmacoepidemiology, Excellent Presentation Award at the 26th Conference of Japanese Society for Pharmacoepidemiology

  抗菌薬・抗真菌薬の使用とスティーヴンス・ジョンソン症候群及び中毒性表皮壊死症のリスク, Japan, Japan society

  Toshiki Fukasawa
• 21 Mar. 2019

  Pharmaceutical Society of Japan, Outstanding Presentation Award at the 139th Annual Meeting of the Pharmaceutical Society of Japan

  抗てんかん薬によるスティーブンス・ジョンソン症候群および中毒性表皮壊死症発症のリスク評価, Japan, Japan society

  Toshiki Fukasawa
• 14 Oct. 2018

  Japanese Society for Pharmacoepidemiology, Incentive Award at the 24th Conference of Japanese Society for Pharmacoepidemiology

  電子カルテデータからスティーブンス・ジョンソン症候群および中毒性表皮壊死症を特定するアルゴリズムの検討, Japan, Japan society

  Toshiki Fukasawa

Media Coverage

• Targeted Reimbursement Encourages Oncology Biosimilar Use

  MJH Life Sciences, The Center for Biosimilars, Business Practice, 07 May 2025, Internet

  
• Trastuzumab Biosimilar Adoption Increased in Japan Due to Reimbursement

  MJH Life Sciences, The Center for Biosimilars, Business Practice, 17 Apr. 2025, Internet

  
• Study Links Osteoporosis Injections and Increased MACE in Dialysis Patients

  Cardiovascular Research Foundation, TCTMD, News, 06 Feb. 2025, Internet

  
• 透析中の骨粗鬆症患者へのデノスマブは心血管イベントリスクを上げる可能性／京都大

  CareNet, Inc., CareNet.com, 論文／ニュース, 23 Jan. 2025, Internet

  
• 透析患者の骨粗鬆症にデノスマブで骨折減少もMACE増加

  M3, Inc., m3.com, 海外ジャーナル, 22 Jan. 2025, Internet

  
• 透析患者の骨粗鬆症に対するデノスマブ、骨折リスク低・心血管イベントリスク増－京大

  QLife, Inc., QLifePro, 医療ニュース, 17 Jan. 2025, Internet

  
• 透析患者に対する骨粗鬆症治療薬の安全性：デノスマブの心血管イベントリスクは？

  Medical Tribune, Inc., Medical Tribune Web, 週刊論文ウォッチ, 16 Jan. 2025, Internet

  
• Adherence to istradefylline in patients with Parkinson's disease: A group-based trajectory analysis

  Medical Data Vision Co., Ltd., MDV EBM insight, RWD × 医学論文解説, 15 Jan. 2025, Internet

  
• Denosumab may increase risk of major adverse cardiovascular events but reduce fracture risk in patients receiving dialysis

  2 Minute Medicine, Inc., 2 Minute Medicine, Chronic Disease, 13 Jan. 2025, Internet

  
• Fracture Risk in Dialysis Population Lower With Denosumab Use

  Haymarket Media, Inc., Renal and Urology News, Dialysis News, 10 Jan. 2025, Internet

  
• 薬剤疫学分野の桝田崇一郎客員研究員、深澤俊貴特定講師、川上浩司教授と整形外科学の松田秀一教授の研究グループが、透析患者におけるデノスマブとビスホスホネートの比較研究をAnnals of Internal Medicine誌に発表しました。

  Kyoto University School of Public Health, News, Generals, 10 Jan. 2025, Internet

  
• Denosumab Increases Cardiovascular Risk in Dialysis-Dependent Patients

  HealthDay, HealthDay News, Bone and Joint, 08 Jan. 2025, Internet

  
• 透析患者における骨粗鬆症治療薬の比較研究―デノスマブは骨折リスク低減も、心血管リスク増加の懸念―

  Kyoto University, Research & Collaborate, 最新の研究成果を知る, 08 Jan. 2025, Internet

  
• Bone cancer drug linked to cardiovascular risk, study suggests

  Becker's Healthcare, Becker's Hospital Review, Pharmacy, 07 Jan. 2025, Internet

  
• Denosumab May Offer Better Fracture Protection for Dialysis Patients

  MedPage Today, LLC, MedPage Today, Endocrinology, 06 Jan. 2025, Internet

  
• ロモソズマブの心血管リスクは他剤と同等：テリパラチドと比較した過去起点コホート研究

  Medical Tribune, Inc., Medical Tribune Web, 医学・医療ニュース, 21 Oct. 2024, Internet

  
• Poor adherence to Nourianz linked to anxiety, mood changes

  Bionews, Inc., Parkinson's News Today, News, 05 Jul. 2024, Internet

  
• Adverse Events Common With Glucocorticoids for Polymyalgia Rheumatica

  HMP Global, First Report Managed Care, News, 17 Apr. 2024, Internet

  
• Comparative effectiveness and safety of edoxaban, rivaroxaban, and apixaban in patients with venous thromboembolism: A cohort study

  Medical Data Vision Co., Ltd., MDV EBM insight, RWD × 医学論文解説, 15 Nov. 2023, Internet

  
• TMP-SMX, Glycopeptides Linked to High Absolute Risk for SJS/TEN in Japan

  Haymarket Media, Inc., Dermatology Advisor, Skin Injury News, 25 Aug. 2023, Internet

  
• Editor’s Comment on "Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with anticonvulsants in a Japanese population: Matched case–control and cohort studies"

  Japanese Society of Allergology, Allergology International, Editor's Choices Archive, 10 Jul. 2021, Paper

  
• New Findings from Keio University Describe Advances in Metabolic Syndrome (Utility of a Specific Health Checkup Database Containing Lifestyle Behaviors and Lifestyle Diseases for Employee Health Insurance in Japan)

  InsuranceNewsNet.com, Inc., InsuranceNewsNet, Insurance Daily News, 03 Feb. 2020, Internet

  

External funds: Kakenhi

• 透析患者における向精神薬の使用実態と安全性に関する薬剤疫学研究

  Grant-in-Aid for Early-Career Scientists

  Basic Section 58030:Hygiene and public health-related: excluding laboratory approach

  Kyoto University

  深澤 俊貴

  From 01 Apr. 2025, To 31 Mar. 2028, Adopted

  https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-25K20625/

Education

Student achievements: Awards

• 日本臨床疫学会第5回年次学術大会優秀賞（非専門家部門）

  Soichiro Masuda, Society for Clinical Epidemiology, 13 Nov. 2022

Student achievements: Papers

• Risk of Fracture Associated with Pregabalin or Mirogabalin Use: A Case-Case-Time-Control Study Based on Japanese Health Insurance Claims Data

  Hinako Wakabayashi, Toshiki Fukasawa, Satomi Yoshida, Kairi Ri, Soichiro Masuda, Takayuki Anno, Koji Kawakami

  May 2025, Second author, Drug Safety, 48, 5, 503, 511, Peer-reviewed, English, Scientific journal, False

  https://doi.org/10.1007/s40264-025-01516-x
• Cefazolin vs. Alternative Beta-lactams for Prophylaxis in Lower Extremity Fracture Surgery: A Target Trial Emulation

  Takaki Yoshiyama, Toshiki Fukasawa, Soichiro Masuda, Shuichi Matsuda, Koji Kawakami

  Feb. 2025, Second author, Injury, 56, 3, 112215, 112215, Peer-reviewed, English, Scientific journal, False

  https://doi.org/10.1016/j.injury.2025.112215
• Comparative effectiveness, persistence, and adherence of dimethyl fumarate and fingolimod in patients with multiple sclerosis in Japan: A cohort study

  Sho Shimazaki, Toshiki Fukasawa, Takayuki Kondo, Masato Takeuchi, Takayuki Okura, Ryosuke Takahashi, Koji Kawakami

  Feb. 2025, Second author, Multiple Sclerosis and Related Disorders, 94, 106306, 106306, Peer-reviewed, English, Scientific journal, False

  https://doi.org/10.1016/j.msard.2025.106306
• Cardiovascular Safety and Fracture Prevention Effectiveness of Denosumab Versus Oral Bisphosphonates in Patients Receiving Dialysis: A Target Trial Emulation

  Soichiro Masuda, Toshiki Fukasawa, Shuichi Matsuda, Koji Kawakami

  Feb. 2025, Second author, Annals of Internal Medicine, 178, 2, 167, 176, Peer-reviewed, English, Scientific journal, False

  https://doi.org/10.7326/annals-24-03237
• Comparison of reoperation incidence after fusion versus decompression for lumbar degenerative disease: A propensity score-weighted study

  Soichiro Masuda, Toshiki Fukasawa, Shunsuke Fujibayashi, Bungo Otsuki, Koichi Murata, Takayoshi Shimizu, Shuichi Matsuda, Koji Kawakami

  Jan. 2025, Second author, Annals of Clinical Epidemiology, 7, 1, 1, 9, Peer-reviewed, English, Scientific journal, False

  https://doi.org/10.37737/ace.25001
• Early prediction of functional impairment at hospital discharge in patients with osteoporotic vertebral fracture: a machine learning approach

  Soichiro Masuda, Toshiki Fukasawa, Shoichiro Inokuchi, Bungo Otsuki, Koichi Murata, Takayoshi Shimizu, Takashi Sono, Shintaro Honda, Koichiro Shima, Masaki Sakamoto, Shuichi Matsuda, Koji Kawakami

  Dec. 2024, Second author, Scientific Reports, 14, 1, 31139, 31139, Peer-reviewed, English, Scientific journal, False

  https://doi.org/10.1038/s41598-024-82359-x
• Assessing the Risk of Gastrointestinal Perforation Associated with COVID-19: A Self-Controlled Case Series Study

  Takayuki Okura, Sachiko Tanaka-Mizuno, Toshiki Fukasawa, Satomi Yoshida, Koji Kawakami

  Dec. 2024, Third author, American Journal of Epidemiology, Peer-reviewed, English, Scientific journal, False

  https://doi.org/10.1093/aje/kwae448
• Impact of Early Resumption of Oral Anticoagulation on Recurrence After Surgery for Chronic Subdural Hematoma in Patients With Atrial Fibrillation: A Target Trial Emulation

  Takayuki Anno, Toshiki Fukasawa, Tomohiro Shinozaki, Masato Takeuchi, Satomi Yoshida, Koji Kawakami

  Dec. 2024, Second author, Pharmacoepidemiology and Drug Safety, 33, 12, e70063, Peer-reviewed, English, Scientific journal, False

  https://doi.org/10.1002/pds.70063
• Comparative effectiveness and cardiovascular safety of romosozumab versus teriparatide in patients with osteoporosis: a population-based cohort study

  Soichiro Masuda, Toshiki Fukasawa, Shuichi Matsuda, Satomi Yoshida, Koji Kawakami

  Dec. 2024, Second author, Osteoporosis International, 35, 12, 2165, 2174, Peer-reviewed, English, Scientific journal, False

  https://doi.org/10.1007/s00198-024-07255-6
• Unchanged incidence of major adverse events amidst rising surgical interventions for osteoporotic vertebral fractures, 2015–2021

  Soichiro Masuda, Toshiki Fukasawa, Bungo Otsuki, Koichi Murata, Takayoshi Shimizu, Takashi Sono, Shintaro Honda, Koichiro Shima, Masaki Sakamoto, Shuichi Matsuda, Koji Kawakami

  Aug. 2024, Second author, Archives of Osteoporosis, 19, 1, 71, 71, Peer-reviewed, English, Scientific journal, False

  https://doi.org/10.1007/s11657-024-01428-w
• Incidence, prevalence, and treatment of Moyamoya disease in Japan: A population-based descriptive study

  Hao Liu, Toshiki Fukasawa, Takayuki Anno, Masato Takeuchi, Sho Shimazaki, Tao Yang, Koji Kawakami

  Aug. 2024, Second author, Journal of Stroke and Cerebrovascular Diseases, 33, 8, 107770, 107770, Peer-reviewed, English, Scientific journal, False

  https://doi.org/10.1016/j.jstrokecerebrovasdis.2024.10
• Association between dental procedures and periprosthetic joint infection: A case-crossover study

  Soichiro Masuda, Toshiki Fukasawa, Masato Takeuchi, Korenori Arai, Shuichi Matsuda, Koji Kawakami

  Jul. 2024, Second author, Journal of Orthopaedic Science, 29, 4, 1145, 1148, Peer-reviewed, English, Scientific journal, False

  https://doi.org/10.1016/j.jos.2023.07.017
• Narcolepsy and risk of traumatic injury: a population-based matched cohort study

  Yunlong Zheng, Toshiki Fukasawa, Soichiro Masuda, Masato Takeuchi, Koji Kawakami

  Oct. 2024, Second author, Journal of Clinical Sleep Medicine, 20, 10, 1657, 1662, Peer-reviewed, English, Scientific journal, False

  https://doi.org/10.5664/jcsm.11236
• Are Dental Procedures Associated With Pyogenic Vertebral Osteomyelitis?

  Soichiro Masuda, Toshiki Fukasawa, Masato Takeuchi, Korenori Arai, Shunsuke Fujibayashi, Bungo Otsuki, Koichi Murata, Takayoshi Shimizu, Shuichi Matsuda, Koji Kawakami

  Apr. 2024, Second author, Clinical Orthopaedics and Related Research, 482, 4, 716, 723, Peer-reviewed, English, Scientific journal, False

  https://doi.org/10.1097/CORR.0000000000002871
• Cardiovascular Safety of Atomoxetine and Methylphenidate in Patients With Attention-Deficit/Hyperactivity Disorder in Japan: A Self-Controlled Case Series Study

  Yunlong Zheng, Toshiki Fukasawa, Fumitaka Yamaguchi, Masato Takeuchi, Koji Kawakami

  Feb. 2024, Second author, Journal of Attention Disorders, 28, 4, 439, 450, Peer-reviewed, English, Scientific journal, False

  https://doi.org/10.1177/10870547231214993
• Frequency and determinants of serum calcium monitoring during eldecalcitol therapy in patients with osteoporosis

  Kairi Ri, Toshiki Fukasawa, Soichiro Masuda, Shiro Tanaka, Masato Takeuchi, Satomi Yoshida, Koji Kawakami

  Nov. 2023, Second author, Journal of Bone and Mineral Metabolism, 41, 6, 890, 900, Peer-reviewed, English, Scientific journal, False

  https://doi.org/10.1007/s00774-023-01470-7
• Predictors of the Need for Surgery in Cervical Ossification of the Posterior Longitudinal Ligament: A Retrospective Cohort Longitudinal Study Using a Claims-based Database

  Soichiro Masuda, Toshiki Fukasawa, Masato Takeuchi, Shunsuke Fujibayashi, Bungo Otsuki, Koichi Murata, Takayoshi Shimizu, Shuichi Matsuda, Koji Kawakami

  Jul. 2023, Second author, Clinical Spine Surgery: A Spine Publication, 36, 6, E271, E276, Peer-reviewed, English, Scientific journal, False

  https://doi.org/10.1097/BSD.0000000000001448
• Incidence of Surgical Site Infection Following Lateral Lumbar Interbody Fusion Compared With Posterior/Transforaminal Lumbar Interbody Fusion: A Propensity Score-Weighted Study

  Soichiro Masuda, Toshiki Fukasawa, Masato Takeuchi, Shunsuke Fujibayashi, Bungo Otsuki, Koichi Murata, Takayoshi Shimizu, Shuichi Matsuda, Koji Kawakami

  Jul. 2023, Second author, Spine, 48, 13, 901, 907, Peer-reviewed, English, Scientific journal, False

  https://doi.org/10.1097/brs.0000000000004587
• Adherence to and persistence with lacosamide, perampanel, lamotrigine, and levetiracetam in adult patients with focal epilepsy in Japan: A descriptive cohort study using a claims database

  Siming Chen, Toshiki Fukasawa, Akio Ikeda, Masato Takeuchi, Akihiro Shimotake, Satomi Yoshida, Koji Kawakami

  Mar. 2023, Second author, Heliyon, 9, 4, e15017, e15017, Peer-reviewed, English, Scientific journal, False

  https://doi.org/10.1016/j.heliyon.2023.e15017
• Risk of parkinsonism and related movement disorders with gabapentinoids or tramadol: A case-crossover study

  Kairi Ri, Toshiki Fukasawa, Satomi Yoshida, Masato Takeuchi, Koji Kawakami

  Feb. 2023, Second author, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 43, 2, 136, 144, Peer-reviewed, English, Scientific journal, False

  https://doi.org/10.1002/phar.2761
• Reoperation Rates of Microendoscopic Discectomy Compared With Conventional Open Lumbar Discectomy: A Large-database Study

  Soichiro Masuda, Toshiki Fukasawa, Masato Takeuchi, Shunsuke Fujibayashi, Bungo Otsuki, Koichi Murata, Takayoshi Shimizu, Shuichi Matsuda, Koji Kawakami

  Jan. 2023, Second author, Clinical Orthopaedics and Related Research, 481, 1, 145, 154, Peer-reviewed, English, Scientific journal, False

  https://doi.org/10.1097/CORR.0000000000002322

Student achievements: Presentations

• Risk of Fracture Associated with Pregabalin or Mirogabalin Use: A Case-Case-Time-Control Study

  Hinako Wakabayashi, Toshiki Fukasawa, Satomi Yoshida, Kairi Ri, Soichiro Masuda, Takayuki Anno, Koji Kawakami

  The 16th Asian Conference on Pharmacoepidemiology, 13 Oct. 2024, From 12 Oct. 2024, To 14 Oct. 2024, Not invited, English, Poster presentation
• ロモソズマブとテリパラチドの骨折予防効果ならびに心血管リスクの比較

  桝田 崇一郎, 深澤 俊貴, 松田 秀一, 吉田 都美, 川上 浩司

  第26回日本骨粗鬆症学会, 11 Oct. 2024, From 11 Oct. 2024, To 13 Oct. 2024, Not invited, Japanese, Poster presentation
• 入院加療を要する骨粗鬆症性椎体骨折患者の退院時ADL不良の予測モデルの開発と検証

  桝田 崇一郎, 深澤 俊貴, 猪口 翔一朗, 大槻 文悟, 村田 浩一, 清水 孝彬, 薗 隆, 本田 新太郎, 嶋 皓一郎, 阪本 将暉, 松田 秀一, 川上 浩司

  第26回日本骨粗鬆症学会, 11 Oct. 2024, From 11 Oct. 2024, To 13 Oct. 2024, Not invited, Japanese, Poster presentation
• 入院加療を要する骨粗鬆症性椎体骨折患者に対する治療法の変遷が全身合併症発生頻度に与える影響

  桝田 崇一郎, 深澤 俊貴, 大槻 文悟, 村田 浩一, 清水 孝彬, 薗 隆, 本田 新太郎, 嶋 皓一朗, 阪本 将暉, 松田 秀一, 川上浩司

  第97回日本整形外科学会学術総会, 26 May 2024, From 23 May 2024, To 26 May 2024, Not invited, Japanese, Oral presentation
• 頚椎後縦靱帯骨化症に対する前方除圧固定術と後方除圧固定術の術後再手術率と医療費の比較

  桝田 崇一郎, 深澤 俊貴, 大槻 文悟, 村田 浩一, 清水 孝彬, 薗 隆, 本田 新太郎, 嶋 皓一朗, 阪本 将暉, 松田 秀一, 川上浩司

  第97回日本整形外科学会学術総会, 25 May 2024, From 23 May 2024, To 26 May 2024, Not invited, Japanese, Poster presentation
• 歯科処置と化膿性脊椎炎の関連 ―ケース・クロスオーバー研究―

  桝田 崇一郎, 深澤 俊貴, 竹内 正人, 新井 是宣, 大槻 文悟, 村田 浩一, 清水孝彬, 松田 秀一, 川上 浩司

  第97回日本整形外科学会学術総会, 25 May 2024, From 23 May 2024, To 26 May 2024, Not invited, Japanese, Poster presentation
• 高齢者における骨粗鬆症性椎体骨折の治療トレンドとその影響

  桝田 崇一郎, 深澤 俊貴, 大槻 文悟, 村田 浩一, 清水 孝彬, 薗 隆, 本田 新太郎, 嶋 皓一朗, 阪本 将暉, 松田 秀一, 川上浩司

  第53回日本脊椎脊髄病学会学術集会, 20 Apr. 2024, From 18 Apr. 2024, To 20 Apr. 2024, Not invited, Japanese, Oral presentation
• 歯科処置は化膿性脊椎炎発症と関連しているか：ケースクロスオーバー研究による評価

  桝田 崇一郎, 深澤 俊貴, 竹内 正人, 新井 是宣, 大槻 文悟, 村田 浩一, 清水孝彬, 松田 秀一, 川上 浩司

  第53回日本脊椎脊髄病学会学術集会, 19 Apr. 2024, From 18 Apr. 2024, To 20 Apr. 2024, Not invited, Japanese, Oral presentation
• Comparison of Reoperation Rates and Cost after Anterior vs. Posterior Decompression and Fusion for Cervical OPLL

  Soichiro Masuda, Toshiki Fukasawa, Bungo Otsuki, Koichi Murata, Takayoshi Shimizu, Takashi Sono, Shintaro Honda, Koichiro Shima, Masaki Sakamoto, Shuichi Matsuda, Koji Kawakami

  第53回日本脊椎脊髄病学会学術集会, 18 Apr. 2024, From 18 Apr. 2024, To 20 Apr. 2024, Not invited, English, Oral presentation
• ナルコレプシー患者における外傷性損傷の発生リスク：マッチド・コホート研究

  鄭 雲龍, 深澤 俊貴, 桝田 崇一郎, 竹内 正人, 川上浩司

  日本臨床疫学会第6回年次学術大会, 11 Nov. 2023, From 11 Nov. 2023, To 12 Nov. 2023, Not invited, Japanese, Oral presentation
• 心房細動患者における慢性硬膜下血腫術後の経口抗凝固薬早期再開と再発の関連：標的試験エミュレーション

  安納 崇之, 深澤 俊貴, 篠崎 智大, 竹内 正人, 吉田 都美, 川上 浩司

  日本臨床疫学会第6回年次学術大会, 11 Nov. 2023, From 11 Nov. 2023, To 12 Nov. 2023, Not invited, Japanese, Poster presentation
• 歯科処置と化膿性脊椎炎の関連：ケース・クロスオーバー研究

  桝田 崇一郎, 深澤 俊貴, 竹内 正人, 新井 是宣, 藤林 俊介, 大槻 文悟, 村田 浩一, 清水孝彬, 松田 秀一, 川上 浩司

  日本臨床疫学会第6回年次学術大会, 11 Nov. 2023, From 11 Nov. 2023, To 12 Nov. 2023, Not invited, Japanese, Poster presentation
• 腰椎側方椎体間固定術と腰椎後方椎体間固定術の術後創部感染発生率の比較

  桝田 崇一郎, 深澤 俊貴, 竹内 正人, 藤林 俊介, 大槻 文悟, 村田 浩一, 清水 孝彬, 松田 秀一, 川上 浩司

  第96回日本整形外科学会学術総会, 13 May 2023, From 11 May 2023, To 14 May 2023, Not invited, Japanese, Oral presentation
• 腰部脊柱管狭窄症に対する固定術は除圧術単独と比較し再手術率低下と関連する

  桝田 崇一郎, 深澤 俊貴, 藤林 俊介, 大槻 文悟, 村田 浩一, 清水 孝彬, 松田 秀一, 川上 浩司

  第96回日本整形外科学会学術総会, 13 May 2023, From 11 May 2023, To 14 May 2023, Not invited, Japanese, Oral presentation
• The reoperation rate of fusion surgery compared with decompression alone for lumbar spinal stenosis

  Soichiro Masuda, Toshiki Fukasawa, Shunsuke Fujibayashi, Bungo Otsuki, Koichi Murata, Takayoshi Shimizu, Shuichi Matsuda, Koji Kawakami

  第52回日本脊椎脊髄病学会学術集会, 14 Apr. 2023, From 13 Apr. 2023, To 15 Apr. 2023, Not invited, English, Poster presentation
• Incidence of surgical site infection following lateral lumbar interbody fusion compared with posterior lumbar interbody fusion

  Soichiro Masuda, Toshiki Fukasawa, Masato Takeuchi, Shunsuke Fujibayashi, Bungo Otsuki, Koichi Murata, Takayoshi Shimizu, Shuichi Matsuda, Koji Kawakami

  第52回日本脊椎脊髄病学会学術集会, 13 Apr. 2023, From 13 Apr. 2023, To 15 Apr. 2023, Not invited, English, Oral presentation
• 多発性硬化症患者におけるフマル酸ジメチルとフィンゴリモドの有効性、 治療継続率、および服薬アドヒアランスの比較

  嶋崎 翔, 深澤 俊貴, 近藤 誉之, 竹内 正人, 大倉 敬之, 高橋 良輔, 川上 浩司

  第27回日本薬剤疫学会学術総会, 18 Nov. 2022, From 17 Nov. 2022, To 19 Nov. 2022, Not invited, Japanese, Oral presentation
• 腰椎側方椎体間固定術と腰椎後方椎体間固定術の術後創部感染発生率の比較

  桝田 崇一郎, 深澤 俊貴, 竹内 正人, 藤林 俊介, 大槻 文悟, 村田 浩一, 清水 孝彬, 松田 秀一, 川上 浩司

  日本臨床疫学会第5回年次学術大会, 13 Nov. 2022, From 12 Nov. 2022, To 13 Nov. 2022, Not invited, Japanese, Oral presentation
• ガバペンチノイドおよびトラマドールによる錐体外路症状のリスク：ケース・クロスオーバー研究

  李 開理, 深澤 俊貴, 吉田 都美, 竹内 正人, 川上 浩司

  第26回日本薬剤疫学会学術総会, 27 Nov. 2021, From 26 Nov. 2021, To 28 Nov. 2021, Not invited, Japanese, Oral presentation

Administration

Faculty management (title, position)

• From 01 Jan. 2021, To 31 Mar. 2023

  社会健康医学系専攻教務委員会 委員

Academic, Social Contribution

Committee Memberships

• From Sep. 2024, To Present

  Member, Pharmacoepi Thesaurus Task Force, Japanese Society for Pharmacoepidemiology
• From Jul. 2024, To Present

  Member, Editorial Board, Japanese Society for Pharmacoepidemiology
• From Nov. 2023, To Present

  Councilor, Japanese Society for Pharmacoepidemiology
• From May 2023, To Nov. 2023

  Committee Member of the 6th Annual Meeting of the Society for Clinical Epidemiology, Society for Clinical Epidemiology
• From May 2023, To Nov. 2023

  Executive Committee Member of the 28th Conference of the Japanese Society for Pharmacoepidemiology, Japanese Society for Pharmacoepidemiology
• From Sep. 2022, To Oct. 2023

  Member, HARPER Translation Working Group, Japanese Society for Pharmacoepidemiology
• From Jan. 2022, To Present

  Member, Expansion Committee, Japanese Society for Pharmacoepidemiology
• From May 2021, To Present

  Member, Ethics Committee of Kyoto University Graduate School and Faculty of Medicine
• From Oct. 2020, To Present

  Member, Ethics Committee of the Research Institute of Healthcare Data Science

Academic Contribution

• Reviewer for Skin Research and Technology

  Peer review

  International Society for Biophysics and Imaging of the Skin

  
• Reviewer for Kidney International

  Peer review

  International Society of Nephrology

  
• Session Chair for the 16th Asian Conference on Pharmacoepidemiology

  Panel moderator

  International Society for Pharmacoepidemiology/Japanese Society for Pharmacoepidemiology, Tokyo, From 14 Oct. 2024, To 14 Oct. 2024

  
• Reviewer for European Journal of Clinical Pharmacology

  Peer review

  European Association for Clinical Pharmacology and Therapeutics

  
• Reviewer for Scientific Reports

  Peer review

  Nature Portfolio

  
• Reviewer for Drugs - Real World Outcomes

  Peer review

  Nature Portfolio

  
• Reviewer for Pharmacoepidemiology and Drug Safety

  Peer review

  International Society for Pharmacoepidemiology

  
• Reviewer for International Journal of Hematology

  Peer review

  Japanese Society of Hematology

  

Social Contribution

• Lecture

  Lecturer

  AstraZeneca K.K., From 25 Apr. 2025, To 25 Apr. 2025

  
• 第81回JMDC Webinar「リアルワールドデータにおける臨床検査値の価値とは？？」

  Panelist

  JMDC Inc., From 20 Feb. 2025, To 20 Feb. 2025

  
• Medical Advisor

  Consultant

  Asahi Kasei Pharma Corporation, From 01 Feb. 2025, To 31 Jan. 2026

  
• Lecture

  Lecturer

  Kyowa Kirin Co., Ltd., From 09 Dec. 2024, To 09 Dec. 2024

  
• 

  JMDC Education Festival 2024 夏 “一緒に学ぼう！ 医療データの世界”

  Lecturer

  JMDC Inc., From 07 Aug. 2024, To 07 Aug. 2024

  
• Advisor

  Consultant

  JMDC Inc., From 26 Jul. 2024, To Present

  
• Pharmacoepidemiology Workshop

  Lecturer

  EPS Corporation, From 10 Mar. 2023, To 10 Mar. 2023

  
• Lecture

  Lecturer

  Kyowa Kirin Co., Ltd., From 24 Jan. 2023, To 24 Jan. 2023

  
• Lecture

  Lecturer

  Kyoto Hokenkai Public Interest Incorporated Association, From 06 Dec. 2022, To 06 Dec. 2022

  
• Research Discussion

  Consultant

  Eisai Co., Ltd., From 02 Dec. 2022, To 02 Dec. 2022

  
• Lecture

  Lecturer

  EPS Corporation, From 02 Nov. 2022, To 02 Nov. 2022

  
• Lecture

  Lecturer

  Asahi Kasei Pharma Corporation, From 09 Aug. 2022, To 09 Aug. 2022

  
• Pharmacoepidemiology Seminar & Workshop

  Lecturer

  EP Croit Co., Ltd., From 11 Mar. 2022, To 11 Mar. 2022

  
• Lecture

  Lecturer

  Eisai Co., Ltd., From 08 Mar. 2022, To 08 Mar. 2022

  
• Lecture

  Lecturer

  Kyowa Kirin Co., Ltd., From 01 Oct. 2021, To 01 Oct. 2021

  
• Pharmacoepidemiology Workshop 2021

  Lecturer

  EP Croit Co., Ltd., From 12 Mar. 2021, To 12 Mar. 2021

  
• Senior Consultant

  Consultant

  リアルワールドデータ株式会社, From 24 Aug. 2020, To 25 Jul. 2024